Test

Mitochondrial replacement therapy has now been used in humans to conceive a “three-parent baby” to prevent inherited mitochondrial disorders, but there remain questions about the effectiveness of the process.

Children with severe cases of epilepsy such as Dravet syndrome are finding new and unexpected cures thanks to determined pediatricians and translational research at UCSF.

To honor and build on a lifetime of giving and charitable service by the late Helen Diller, the Helen Diller Foundation has granted $500 million to UCSF, the largest single donation in UCSF’s history and one of the largest ever to a U.S. university.

UCSF researchers are working to figure out how mouse stem cells divide and differentiate into acinar cells to rebuild the salivary gland after an injury. Such research could apply to patients who often lose the ability to produce saliva after undergoing radiation therapy for head and neck cancers.

Over the next year, 19 new public water stations will be installed across San Francisco, thanks to a collaboration involving the City and County of San Francisco, community groups, and UCSF Health.

A UC San Francisco-led study has identified signatures of ethnicity in the genome that appear to reflect an ethnic group’s shared culture and environment, rather than their common genetic ancestry.

UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation have renewed an agreement to identify and develop biologic compounds against both known and novel targets.

Jeff Sheehy, the longtime director of communications at UC San Francisco’s Aids Research Institute, has been appointed by San Francisco Mayor Edwin M. Lee to serve on the San Francisco Board of Supervisors.

The first undocumented immigrant to attend UC San Francisco’s School of Medicine, Jirayut “New” Latthivongskorn, has been named to the 2017 “30 Under 30” list by Forbes magazine.

Stephen J. Barclay, the former senior vice chancellor of Finance and Administration who guided UCSF through state budget cutbacks as well as the planning of the Mission Bay campus, has died. He was 70.

Researchers at UCSF have developed a new optogenetic tool that can be used to completely eliminate single cells from brain networks in animals. The researchers believe the new tool will enable exquisitely precise experiments to help researchers understand how each cell contributes to the whole.

Steven Altschuler and Lani Wu are using artificial intelligence to spot and label potential medical uses for biological compounds.

Alcohol abuse may increase the risk for heart attack, atrial fibrillation and congestive heart failure.

Latino children with kidney failure have a surprising survival advantage over white children despite longer waits for transplants, according to a UCSF study that tracked more than 12,000 pediatric patients.

The UCSF community is deeply saddened to learn of the passing of William K. Bowes Jr., a Bay Area venture capitalist whose dedicated volunteer service and generous philanthropy supported medical research, access to college, higher education and the arts.

UC San Francisco researchers have discovered a way to switch off the widely used CRISPR-Cas9 gene-editing system using newly identified anti-CRISPR proteins that are produced by bacterial viruses.

A newly identified bacterial protein that is shown to jump-start infection may be the culprit in a foodborne disease that strikes pregnant women in disproportionately high numbers, leading to miscarriage and pre-term birth.

Margot Kushel’s research, clinical and personal work with homeless patients stretches back to the 1990s when she was a medical resident at ZSFG.

In findings that show the effectiveness of a new strategy for treating multiple sclerosis, researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab in both relapsing multiple sclerosis and primary progressive multiple sclerosis.

UCSF is joining a unique collaboration agreement with Facebook that would allow its researchers to engage in joint technology projects without the usual red tape.